Query author contributions in Reactome
Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.
If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.
Details on Person Normally in humans, adenosine and deoxyadenosine can be deam...
| Class:Id | Summation:9734744 |
|---|---|
| _displayName | Normally in humans, adenosine and deoxyadenosine can be deam... |
| _timestamp | 2021-06-18 18:44:19 |
| created | [InstanceEdit:9734740] D'Eustachio, Peter, 2021-06-18 |
| modified | [InstanceEdit:9734758] D'Eustachio, Peter, 2021-06-18 |
| text | Normally in humans, adenosine and deoxyadenosine can be deaminated to inosine and deoxyinosine, catalyzed by ADA (adenosine deaminase). In the absence of ADA activity, however, accumulated nucleosides disrupt lymphoid cell function, leading to severe combined immunodeficiency. Here, we have annotated the failure of normal adenosine and deoxyadenosine deamination due to three missense mutant alleles of ADA, identified in patients with severe combined immunodeficiency and shown to encode unstable or catalytically inactive forms of ADA protein (Hirschhorn et al. 1989, 1990). |
| (summation) | [FailedReaction:9734745] Defective ADA does not deaminate (deoxy)adenosine [Homo sapiens] |
| [Change default viewing format] | |
No pathways have been reviewed or authored by Normally in humans, adenosine and deoxyadenosine can be deam... (9734744)
